VolitionRX Limited (VNRX)
Soligenix Inc. (SNGX)
BioSig Technologies Inc. (BSGM)
Soligenix Inc. (SNGX)
SeqLL Inc (merged with with Lyneer Investments, LLC (“Lyneer”)) (SQL)
Collegium Pharmaceutical Inc (COLL)
Entero Therapeutics Inc. (ENTO)
New Form 8-K - Entero Therapeutics, Inc. Filed: 2025-08-15 AccNo: 0001104659-25-079322 Size: 250 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
ProPhase Labs Inc. (PRPH)
BioVie Inc. (BIVI)
MacroGenics Inc (MGNX)
Guardant Health Inc (GH)
Guardant Health, Inc. - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guardant Health Inc (GH)
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)